Michael D Lieberman MD
Colon & Rectal Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Associate Professor of Surgery, Cornell University-Weill Medical College
525 E 68th StSuite M014New York, NY 10021
Fax+1 212-746-5845
Overview of Dr. Lieberman
Dr. Michael Lieberman is a general surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 41 years. Dr. Lieberman accepts several types of health insurance, listed below. He is one of 392 doctors at New York-Presbyterian Hospital and one of 137 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in General Surgery. He has more than 40 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemResidency, Surgery, 1985 - 1992
Rutgers New Jersey Medical SchoolClass of 1985
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 1978 - 2028
NJ State Medical License 1981 - 2025
PA State Medical License 1987 - 1992
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015, 2017
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Corrigendum to "Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels n...Jesús Delgado-de la Mora, Majd Al Assaad, Selda Karaaslan, Kevin Hadi, Ahmed Halima
Pathology, Research and Practice. 2025-02-01 - 2 citationsWhole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fu...Jesús Delgado-de la Mora, Majd Al Assaad, Selda Karaaslan, Kevin Hadi, Ahmed Halima
Pathology, Research and Practice. 2025-02-01 - 2 citationsA targetable pathway to eliminate TRA-1-60+/TRA-1-81+ chemoresistant cancer cells.Lei Tan, Xiaohua Duan, Pratyusha Mutyala, Ting Zhou, Sadaf Amin
Journal of Molecular Cell Biology. 2023-11-27
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOHIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: